Chronic Venous Insufficiency: Swelling, Skin Changes and Ulcer Care

Chronic venous insufficiency can cause persistent leg swelling, skin damage and ulcers; care needs an assessed cause and an arterial safety check before compression. Confidence is high in the need for assessment. New unilateral swelling or symptoms of a lung clot require prompt care rather than being attributed to an old diagnosis.

Table of contents

• Evidence summary: identify reflux, obstruction and skin risk
• What chronic venous insufficiency means
• Why pressure affects the skin
• Compression, skin care and selected vein treatment
• What circulation supplements have not established
• Make the plan feasible
• A chronic label should not hide an acute problem
• Skin products and medicines need an explained plan
• Who needs specialist or wound care?
• Questions that clarify follow-up
• Biomarkers are not a valve-repair verdict
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary: identify reflux, obstruction and skin risk

Confidence is high that persistent venous swelling, skin damage or ulcers need assessment and a treatment plan. The best procedure depends on the location of reflux or obstruction and the person’s risks. This review does not independently rank stents, dressings, compression brands or supplement products.

The ESVS definition reserves chronic venous insufficiency for more advanced disease with swelling, skin changes or ulcers, corresponding to CEAP C3–C6. “Chronic venous disease” is broader. A visible varicose vein alone is therefore not interchangeable with advanced insufficiency. Original terminology.

What chronic venous insufficiency means

Leg veins return blood toward the heart. Their valves and surrounding muscle activity help this return. Faulty valves allow backward flow, called reflux; an obstructed drainage pathway can also contribute. These are anatomical questions a vascular assessment can distinguish. Original venous disease guidance.

Symptoms can include ankle swelling, aching or heaviness, while skin may become itchy, discoloured or hardened. Venous eczema can look red or brown on lighter skin and dark brown, purple or grey on darker skin. Skin damage can progress to a wound that needs care. Skin manifestations.

CVI is not the only explanation for leg swelling. A clinician needs to consider the history, distribution and examination rather than diagnose venous disease from a photograph. Ask what findings support the diagnosis and whether another condition also contributes.

Why pressure affects the skin

Persistent pressure in leg veins can allow fluid into nearby tissues. Prior DVT can damage valves and affect later venous function. Reduced movement, pregnancy and other individual factors may contribute. A previous clot is important history, but it does not mean every subsequent episode of swelling is an old-clot symptom. Venous pressure context.

Swelling that worsens after prolonged standing and improves with elevation can occur with venous problems. That pattern is useful to report, yet it does not by itself exclude an acute clot or another cause. Symptom pattern.

An assessment should describe the actual problem: superficial reflux, deep venous disease, obstruction, or a combination. “Poor circulation” is too vague to explain which treatment is appropriate. Ask for the result in plain language, including whether the arteries have also been assessed.

Compression, skin care and selected vein treatment

Compression supports venous return and can be used in an assessed plan. It must be appropriate to arterial blood supply and the person’s circumstances. In suspected venous ulcers, NHS information describes ankle/arm pressure assessment before compression because low arterial pressures can make it unsafe. Arterial safety assessment.

Venous eczema may need moisturisers and a prescribed topical corticosteroid for inflammation. Treating the skin and treating venous pressure are related but distinct aims. A skin cream does not correct every underlying vein problem. Skin treatment context.

Selected superficial reflux may be treated by ablation, foam or surgery; deep obstruction needs a different specialist decision. A procedure should follow an explained anatomical assessment. A recommendation for one type of reflux should not be expanded into routine stenting for every swollen leg. Assessment and intervention context.

What circulation supplements have not established

This review establishes no supplement that repairs damaged valves, removes a venous obstruction or replaces ulcer treatment. A claim about “circulation” does not identify whether the evidence concerns symptoms, blood-flow measurements or a clinically meaningful outcome.

NHS eczema information describes limited evidence for complementary approaches and advises continuing prescribed care. NCCIH also explains that products may differ from tested preparations and can interact with medicines or affect surgery. Complementary-therapy limits; General safety.

A deficiency can deserve treatment separately. It should not be assumed from leg discoloration or swelling. Ask for the actual diagnosis and a relevant human evidence base rather than treating a marketing description as a clinical indication.

Make the plan feasible

Appropriate movement, breaks from prolonged immobility, elevation and skin care can be part of day-to-day management. Ask how these fit your mobility, pain and other health conditions rather than copying a rigid exercise or elevation schedule. Daily management context.

Compression needs practical support: correct fitting, a way to put it on and remove it, and a plan if it becomes uncomfortable. NHS prevention information describes clinician-selected stockings and aids. A garment that cannot be used safely or consistently needs review. Fitting and prevention context.

Track outcomes that matter: swelling, walking comfort, itching, wound progress and ability to use treatment. Photographing a wound may help the care team if done as instructed, but an image does not replace examination or a professional wound measurement.

A chronic label should not hide an acute problem

New one-sided leg pain and swelling need prompt assessment for DVT. If accompanied by chest pain or breathlessness, seek emergency care for possible pulmonary embolism. Do not assume these are routine CVI symptoms or try to resolve them with massage or tighter compression. Current DVT safety guidance.

A painful wound with spreading changes, increasing discharge or feeling unwell may be infected and needs clinical review. Antibiotics address infection when indicated; they are not a substitute for the underlying ulcer care. Ulcer infection context.

If a compression bandage causes unusual pain, numbness, tingling or pale/blue toes, obtain urgent advice and follow the service’s removal instructions; NHS ulcer guidance says to remove or cut off the bandage and contact the clinician promptly in these circumstances. Compression warning signs.

Skin products and medicines need an explained plan

Prescribed topical steroids have different strengths and durations. Use the actual instructions and seek review if the skin does not improve or develops a new reaction. Dressings and creams can themselves cause sensitivity; do not assume every new rash is progression of the venous condition. Skin and dressing review.

Emollients can leave flammable residue on clothing or bedding; avoid flames and smoking near them. Greasy products may also make surfaces slippery. This safety issue applies independently of whether the moisturiser improves symptoms. Emollient precautions.

Tell the vascular team about anticoagulants, antiplatelets and supplements before a procedure. Do not stop prescribed clot-prevention treatment on your own. Request a coordinated plan when different clinicians manage the wound, vein disease and medicines. Procedural supplement precautions.

Who needs specialist or wound care?

A persistent leg wound should be assessed for its cause. NHS information identifies venous, arterial, diabetic, inflammatory and other ulcer types; appearance alone does not establish the correct pathway. A sore that has not healed after two weeks deserves clinical review. Ulcer overview.

Assessment is particularly useful for skin hardening or eczema, recurrent ulcers, persistent swelling or symptoms limiting daily life. Bring any history of DVT, injury, surgery and prior interventions. Ask whether the evaluation covers both arterial safety and the venous anatomy.

Venous ultrasound helps examine flow and plan treatment. It should be interpreted with symptoms and examination rather than treated as a reason to intervene on every abnormality. Diagnostic context.

Questions that clarify follow-up

Ask what is causing the high venous pressure, what each treatment should improve and what would count as insufficient progress. Is the main goal symptom relief, skin protection, ulcer healing or correction of a selected reflux pathway? These goals can require different plans.

For an ulcer, agree who will review healing and how to contact the service about pain, dressing problems or infection concerns. Treatment is more than choosing a dressing: NHS guidance describes professional cleaning, dressing and skilled compression. Wound-care context.

After healing, recurrence prevention may include suitable compression and addressing underlying venous problems. Ask for a plan you can sustain and a review if the garment no longer fits or a wound returns. Healing once is not proof that the underlying pressure has disappeared. Recurrence prevention.

Biomarkers are not a valve-repair verdict

Animal models and laboratory measures of inflammation or vascular tone can suggest mechanisms. They cannot establish human ulcer healing, safe compression or correction of venous reflux. None is used here as an efficacy verdict.

Funding and source roles

The complete 2022 ESVS original and relevant methodology were opened. Its no-industry-development-support statement is narrower than independence of the authors, society or supporting trials. NICE’s original indexed quality statement is attributed policy; direct access was blocked and complete original trial/committee appendices were not read. Actual 2025–26 NICE income records show several revenue routes. Public educational material supplies descriptive and safety context, not a blanket clearance of treatment evidence.

Tier describes financial proximity; A–D describes credibility for the stated source role. Neither is a clinical certainty grade. Unknown finances remain unknown. Manufacturer- and sponsor-funded efficacy is excluded from the independent verdict; attributed clinical guidance is identified as guidance.

Frequently asked questions

Is every swollen leg CVI?
No. The history and examination need to assess other explanations.

Are varicose veins and CVI identical?
No. CVI generally describes advanced venous dysfunction with swelling, skin changes or ulcers.

Can I buy the strongest compression stockings?
Do not select pressure by guesswork; arterial assessment, fitting and clinical advice matter.

Do antibiotics heal a venous ulcer?
They treat infection when indicated; the underlying wound and venous care remain necessary.

Can an old DVT explain all new swelling?
It can affect long-term veins, but new symptoms still need assessment for acute problems.

Sources and funding notes

The full ESVS guideline, actual NICE account income note and the cited public patient pages were checked. NICE QS67 indexed original text was accessible while its direct page returned 403; no full CG168 author/trial audit is claimed. NHS eczema pages passed their April 2026 review dates; ulcer pages passed November 2025. Their role is basic assessment and safety, with no exact healing rate, compression dose or product ranking.

• NHS: varicose veins, July 2024 — Visible veins, symptoms and clinical pathways.
• NHLBI: varicose veins, September 2023 — Valve reflux, procedure risks and recurrence.
• NHS: varicose eczema, April 2023 — Venous pressure and skin change; April 2026 review due date passed.
• NHS: varicose eczema treatment, April 2023 — Skin treatment and emollient precautions; review due date passed.
• NHS: venous leg ulcer, November 2022 — Ulcer definition and broader differential; November 2025 review date passed.
• NHS: ulcer treatment, November 2022 — Skilled compression and infection safety; review date passed.
• NHS: ulcer diagnosis, November 2022 — Arterial assessment before compression; review date passed.
• NHS: ulcer prevention, November 2022 — Clinician-selected recurrence prevention; review date passed.
• NHS: DVT, April 2026 — New unilateral swelling and pulmonary-embolism warning signs.
• ESVS: original 2022 chronic venous disease guideline — CVI definition, reflux/obstruction and assessment limits.
• NICE: QS67 treatment quality statement, 2014 — Suitable treatment order for confirmed truncal reflux; original indexed text read, direct page returned 403.
• NICE: 2025–26 annual accounts — Institutional funding trace; no efficacy role.
• ESVS: documents/statutes — Society revenue route, not clearance of personal interests.
• NCCIH: supplement safety — Interactions and surgical precautions.
• NHLBI: budget and gift authority — Funding trace, not outcome evidence.
• NHS website: content and funding policy — Website funding and editorial safeguards only.

Last reviewed: October 4, 2026. Educational information; no personal diagnosis, medication dose or supplement regimen is supplied. Local approval, product labels and clinical circumstances may differ.